Back to Search Start Over

Acetylcholine receptors (muscarinic) in GtoPdb v.2021.3

Authors :
Neil M. Nathanson
Jürgen Wess
Rudolf Hammer
R. A. John Challiss
Richard M. Eglen
Fred Mitchelson
David Brown
Sophie J. Bradley
Celine Valant
Heinz Kilbinger
Chris Langmead
Frederick J. Ehlert
Andrew B. Tobin
Noel J. Buckley
Ernst Mutschler
Günter Lambrecht
Arthur Christopoulos
David M. Thal
Roy D. Schwarz
Nigel J. M. Birdsall
Christian C. Felder
Source :
IUPHAR/BPS Guide to Pharmacology CITE. 2021
Publication Year :
2021
Publisher :
Edinburgh University Library, 2021.

Abstract

Muscarinic acetylcholine receptors (mAChRs) (nomenclature as agreed by the NC-IUPHAR Subcommittee on Muscarinic Acetylcholine Receptors [50]) are activated by the endogenous agonist acetylcholine. All five (M1-M5) mAChRs are ubiquitously expressed in the human body and are therefore attractive targets for many disorders. Functionally, M1, M3, and M5 mAChRs preferentially couple to Gq/11 proteins, whilst M2 and M4 mAChRs predominantly couple to Gi/o proteins. Both agonists and antagonists of mAChRs are clinically approved drugs, including pilocarpine for the treatment of elevated intra-ocular pressure and glaucoma, and atropine for the treatment of bradycardia and poisoning by muscarinic agents such as organophosphates.

Details

ISSN :
26331020
Volume :
2021
Database :
OpenAIRE
Journal :
IUPHAR/BPS Guide to Pharmacology CITE
Accession number :
edsair.doi...........21748271f1e349fb133f34951200f47b